Coronary Intervention & Surgery

Joseph D. Babb, MD—who performed the first coronary angioplasty in the state of Connecticut and was a past president of the Society for Cardiovascular Angiography and Interventions (SCAI)—has died, SCAI announced Sept. 6. He was 79.

The family of a Tennessee man who died in 2017, one month after open-heart surgery, is suing TriStar Centennial hospital, alleging the surgeon left a needle inside his body.

Late-breaking results from the VISION study, presented early this week at the European Society of Cardiology (ESC)’s annual symposium, found nearly three-quarters of patient deaths after noncardiac surgery can be attributed to cardiovascular causes.

For patients with acute myocardial infarction (MI) complicated by cardiogenic shock, stenting only the culprit lesion showed a trend toward improved one-year survival when compared to multivessel PCI, according to the latest results of the CULPRIT-SHOCK trial presented at the European Society of Cardiology Congress in Munich.

Intravascular ultrasound may help identify patients who will benefit most from distal protection during percutaneous coronary intervention (PCI), according to a new study published in JACC: Cardiovascular Interventions.

The Avert system successfully reduced contrast media volume but failed to trim the risk of acute kidney injury (AKI) following coronary angiography, according to a trial published in JACC: Cardiovascular Interventions.

The same investigators who ignited debate among interventional cardiologists with the ORBITA trial in November 2017 have now published a small study highlighting the ability of percutaneous coronary intervention (PCI) to immediately reduce ischemia and boost patients’ exercise capacity.

Transcatheter aortic valve replacement (TAVR) has provided relief to thousands of Americans who suffer from leaky heart valves and are too frail to undergo open-heart surgery. But policy and business considerations behind TAVR has large and small hospitals fighting over who will perform the procedures.

The Cleveland Clinic was named the top hospital in the country for cardiology and heart surgery by the U.S. News & World Report—a distinction it has held since 1995.

Shorter reperfusion times for patients with ST-segment elevation myocardial infarction (STEMI) are associated with fewer cases of in-hospital heart failure and fewer readmissions for heart failure over the next 30 days, according to an observational study from Singapore published in Circulation: Cardiovascular Quality and Outcomes.

Instantaneous wave-free ratio (iFR) and fractional flow reserve (FFR) were equally safe in deferring patients from coronary revascularization, according to a pooled analysis of two randomized trials published Aug. 6 in JACC: Cardiovascular Interventions.

Patients with chronic kidney disease (CKD) who undergo coronary revascularization experience fewer adverse events in the short term with PCI compared to coronary artery bypass grafting (CABG) but similar three-year risks of death, stroke or heart attack.